1-2 of 2
M G Rosenblum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.

Free
L C Pagliaro, B Liu, R Munker, M Andreeff, E J Freireich, D A Scheinberg, M G Rosenblum
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (8): 1971–1976.
Published: 01 August 1998
View article titled, Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Open the PDF for Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity. in another window
Journal Articles

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

Free
D J Macey, E J Grant, L Kasi, M G Rosenblum, H Z Zhang, R L Katz, P T Rieger, D LeBherz, M South, J W Greiner, J Schlom, D A Podoloff, J L Murray
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1547–1555.
Published: 01 September 1997
View article titled, Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
Open the PDF for Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial. in another window